Jones Mark Evan 4
4 · Goosehead Insurance, Inc. · Filed Aug 20, 2024
Insider Transaction Report
Form 4
Jones Mark Evan
DirectorExecutive Chairman10% OwnerOther
Transactions
- Exercise/Conversion
Class A Common Stock
2024-08-16$10.00/sh+10,418$104,180→ 49,869 total - Sale
Class A Common Stock
2024-08-16$85.88/sh−10,418$894,698→ 39,451 total - Exercise/Conversion
Class A Common Stock
2024-08-19$10.00/sh+11,699$116,990→ 51,150 total - Sale
Class A Common Stock
2024-08-19$85.38/sh−7,053$602,185→ 44,097 total - Sale
Class A Common Stock
2024-08-19$86.30/sh−4,546$392,320→ 39,551 total - Sale
Class A Common Stock
2024-08-19$87.04/sh−100$8,704→ 39,451 total - Exercise/Conversion
Employee Stock Options (right to buy)
2024-08-16$10.00/sh−10,418$104,180→ 34,906 totalExercise: $10.00Exp: 2028-04-26→ Class A Common Stock (10,418 underlying) - Exercise/Conversion
Employee Stock Options (right to buy)
2024-08-19$10.00/sh−11,699$116,990→ 23,207 totalExercise: $10.00Exp: 2028-04-26→ Class A Common Stock (11,699 underlying)
Footnotes (5)
- [F1]This does not reflect shares directly held by the reporting person's spouse, who is independently a reporting person of the issuer.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.56 to $86.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.02 to $86.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F5]One third (1/3rd) of the option, which represents the right to purchase a total of 320,000 shares, vested and became exercisable, subject to continued employment, on each of the second, third and fourth anniversaries of the grant date, which was April 26, 2018.